Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Buy City of London Investment Group (CLIG) by Mark Rogers in The Motley Fool
- Buy Barclays (BARC) by Charlie Keough in The Motley Fool
- Neutral Land Securities Group (LAND) by JP Morgan
- Buy BT Group (BT.A) by Berenberg
- Sell Sage Group (SGE) by Canaccord Genuity
- Buy Secure Trust Bank (STB) by Berenberg
- Speculative Buy Hummingbird Resources (HUM) by Canaccord Genuity
- Hold M&G (MNG) by Berenberg
- Buy FD Technologies Public Limited Company (FDP) by Shore Capital
- Hold Land Securities Group (LAND) by Shore Capital
- Buy Tritax Big Box Reit (BBOX) by Shore Capital
- Buy Devolver Digital, Inc. (DI) Reg S Cat 3/144A (DEVO) by Shore Capital
- Watch Supermarket Income Reit (SUPR) by Jon Smith in The Motley Fool
- Buy Rolls-Royce Holdings (RR.) by Jon Smith in The Motley Fool
- Avoid Proteome Sciences (PRM) by Steve Moore in ShareProphets
- Buy Phoenix Group Holdings (PHNX) by Christopher Ruane in The Motley Fool
- Hold Britvic (BVIC) by Jefferies
- Watch Watches of Switzerland Group (WOSG) by Steve Moore in ShareProphets
- Watch Darktrace (DARK) by Gordon Best in The Motley Fool
MGC Pharmaceuticals Limited NPV (DI) (MXC) Share Price
Health Care Sector
NOTE: This is based on 9 open tips for MGC Pharmaceuticals Limited NPV (DI) (MXC)
| Latest Bid : 21.00p | Latest Ask : 23.00p |
| High Today : 22.90p | Low Today : 21.10p |
| This Years High : 550.00p | This Years Low : 18.00p |
| Volume : 3,655 | MKT Cap : £722.92M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
MGC Pharmaceuticals Limited NPV (DI) (MXC) Overview
MGC Pharmaceuticals Limited is a bio-pharma company with a "Nature to Medicine" strategy within the international phytocannabinoid and plant-derived medicines industry. With operations through its subsidiaries in Australia, the European Union and the UK (the "Group"), the Company is developing phytocannabinoid-derived and plant-derived medicines as well as unique formulations, both proprietary and for third parties, all to GMP standard.MGC Pharmaceuticals Limited NPV (DI) (MXC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Speculative Buy | Canaccord Genuity | Premium Only | 2023-03-22 13:31:00 22/03/2023 | -96.00% |
| Sell | Tom Winnifrith | Premium Only | 2023-02-03 10:55:00 03/02/2023 | 96.00% |
| Sell | Tom Winnifrith | Premium Only | 2022-09-04 17:10:00 04/09/2022 | 97.85% |
| Sell | Tom Winnifrith | Premium Only | 2022-07-08 12:00:00 08/07/2022 | 97.54% |
| Sell | Tom Winnifrith | Premium Only | 2022-06-16 16:00:00 16/06/2022 | 97.80% |
MGC Pharmaceuticals Limited NPV (DI) (MXC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 21.00p | Latest Ask : 23.00p |
| High Today : 22.90p | Low Today : 21.10p |
| This Years High : 550.00p | This Years Low : 18.00p |
| Volume : 3,655 | MKT Cap : £722.92M |
MGC Pharmaceuticals Limited NPV (DI) Overview
MGC Pharmaceuticals Limited is a bio-pharma company with a "Nature to Medicine" strategy within the international phytocannabinoid and plant-derived medicines industry. With operations through its subsidiaries in Australia, the European Union and the UK (the "Group"), the Company is developing phytocannabinoid-derived and plant-derived medicines as well as unique formulations, both proprietary and for third parties, all to GMP standard.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest MGC Pharmaceuticals Limited NPV (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Speculative Buy | Canaccord Genuity | Premium Only | 2023-03-22 13:31:00 22/03/2023 | -96.00% |
| Sell | Tom Winnifrith | Premium Only | 2023-02-03 10:55:00 03/02/2023 | 96.00% |
| Sell | Tom Winnifrith | Premium Only | 2022-09-04 17:10:00 04/09/2022 | 97.85% |
| Sell | Tom Winnifrith | Premium Only | 2022-07-08 12:00:00 08/07/2022 | 97.54% |
| Sell | Tom Winnifrith | Premium Only | 2022-06-16 16:00:00 16/06/2022 | 97.80% |